spacer
home > directory > Datwyler Sealing Solutions
PHARMACEUTICAL INDUSTRY DIRECTORY

Datwyler Sealing Solutions

Datwyler Sealing Solutions
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global healthcare world. Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our healthcare offering, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Based on a broad range of experience in the healthcare industry and extensive material science expertise, we offer a full service offering to better help our customers determine the ideal solution for their parenteral packaging needs. Partnering with the world’s top pharmaceutical and medical companies, we stand by our mission to ensure all patient’s safety and improve patients’ lives.
phone +41 41 875 11 23
email sealing.ch@datwyler.com
web https://sealing.datwyler.com/
email Militärstrasse 7 CH-6467 Schattdorf Switzerland
 
spacer

Member login

E-mail address:

Password:
Remember me

Industry Events

Clinical Trials Europe | Partnerships, Outsourcing, Operations & Technology

27 August - 21 November 2019, Barcelona, Spain

On 19-21 November 2019, the clinical trial community's most influential stakeholders will be meeting in Barcelona to discuss the evolving landscape, honing in on what it takes to harness true value from partnerships, outsourcing, operations, technology and early clinical development, for a faster, more efficient route to market.
More info >>

 
News and Press Releases

Huge boom in Korean Pharma reported at CPhI Korea

Amsterdam, 19th September 2019: The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders Association (KPTA) – has seen a surge in growth across domestic and international pharma companies, as well as a sizable rise in overall attendees. As reported earlier this year in the provisional findings of the CPhI Pharma Index[1], Korea has seen a rapid growth in its international reputation (seeing its ‘overall competitiveness’ rise 14% in the last two years), which is now translating into a sizable growth in the market and at the event.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement